NeuroTherapy Ventures: Catalyzing Neurologic Innovations

Henry W. Chesbrough

Description: Discusses the impact of limited market size on epilepsy therapies and shows how an early-stage venture fund can catalyze faster development of new treatments.

 More information: http://cb.hbsp.harvard.edu/cb/web/product_detail.seam?R=602124-PDF-ENG&conversationId=249439&E=36620

learning objective: Illustrates potential market failures for new drug development in epilepsy market and shows novel organizational vehicle to commercialize greater innovation from epilepsy research